4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Treatment of PCEDConjunctival Diseases, Conjunctivitis, Allergic, Hypersensitivity, Immediate, conjunctivitis, eye disorder, immune system disorderRecruitingPhase 32026-10-07NCT07519902
Extension Study for the Port Delivery System With Ranibizumab (Portal)Neovascular Age-Related Macular DegenerationRecruitingPhase 32026-09-28NCT03683251
Hydrus® Microstent New Enrollment Post-Approval StudyGlaucoma, Primary Open Angle, eye disorder, glaucoma, ocular hypertension, open-angle glaucomaRecruitingNot applicable2026-09-22NCT04553523
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2neurotrophic keratopathyRecruitingPhase 32025-12-23NCT05555589